Navigation Links
Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US
Date:6/20/2011

VICTORIA, Australia, June 20, 2011 /PRNewswire/ -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE), through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen™ genetic test for assessing non-familial breast cancer risk.  

Phenogen Sciences will target its promotion campaign on women's health clinics in over 20 US metro-markets.  The company has deployed its sales force to service select markets based on high volume use of the BRCA genetic test, currently available for the rarer familial form of breast cancer.  The BREVAGen™ test has an attractive gross margin and an estimated addressable market in excess of $600 million per annum in the US.

"The US launch of BREVAGen™ is the culmination of substantial investment in development encompassing large scale genomic investigations and substantial support in medical literature.  It is the first phase of the company's five year strategy to build a global cancer diagnostics business," said Dr. Paul MacLeman, CEO.

"Over this same period, GTG's core business has been streamlined; cutting costs, culling poor performing products and delivering its maiden half year profit.  GTG has a clear focus on providing the best possible cancer diagnostics in major world markets.  The US launch of BREVAGen™ follows the establishment of core commercial capability in the US and the achievement of CLIA certification for the company's now globally accredited laboratory."

"GTG is now also actively assessing new synergistic M&A opportunities with a view to a possible transaction during the coming financial year."

The new BREVAGen™ genetic test will be combined with individual risk factors to assess a patient's five-year and lifetime risk for the more frequent forms of sporadic/non-hereditary breast cancer that represent over 90 pe
'/>"/>

SOURCE Genetic Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. A knockout resource for mouse genetics
2. Biochemist and Geneticist Ronald W. Davis Receives $500,000 Gruber Genetics Prize for Pioneering Work in the Development of Biotechnologies that Have Significantly Advanced the Fields of Molecular Genetics and Genomics
3. Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics
4. AIBioTech Working with FDA to Ensure New Genetic Test Remains Available to Consumers
5. Syngenta to Invest in New U.S. Genetics Research Facility
6. Reportlinker Adds Genetics Reports Bundle
7. Transgenomic, Inc. Enhances FAMILION® Genetic Test Offerings
8. New Genetic Test Helps Athletes Maximize Performance, Identify Undiagnosed Risk Factors
9. Nobel Winner Baruch Blumberg, Viral Genetics Advisor, Dies at 85
10. Reportlinker Adds Cytogenetics - Technologies, Markets and Companies
11. Ambry Genetics is First Authorized Customer Service Provider in New Ion Torrent CSP Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has submitted an additional ... and Drug Administration (FDA), which brings the Company,s total ... eighteen submissions now pending at the FDA. ... the Company, commented, "Our team here at IGI has ...
(Date:11/24/2014)...   Veracyte, Inc. (Nasdaq: VCYT ) ... chief executive officer, will present in a fireside chat discussion ... on Tuesday, December 2, 2014 at 12:30 p.m. ET in ... audio webcast and subsequent replay may be accessed by visiting ... website at least 15 minutes prior to the live webcast ...
(Date:11/24/2014)... 24, 2014  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today ... Ltd.,  Case No. 3:13-cv-03494-M and  Spherix v. Uniden ... in the United States District Court for the ... On November 21, 2014 the ...
(Date:11/22/2014)... Boston, MA (PRWEB) November 21, 2014 ... and key investors will gather on December 3rd ... Boston Biotech Conferences series. GeneticRx will take place ... Harvard Medical School and will discuss the present ... gene therapy, exon skipping, and gene editing—as well ...
Breaking Biology Technology:IGI Laboratories, Inc. Announces ANDA Submission 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... introduced the world to tiny robots demonstrating soccer ... competition designed to advance microroboticsthe field devoted to ... dimensions are measured in micrometers (millionths of a ... Technology (NIST), in collaboration with IEEE, is inviting ...
... While other states jockeyed for position on Business ... its ranking as best in the Midwest and No. ... bioscience industry . , (Logo: ... bioscience ranking is in part due to updated estimates ...
... A faster tool for cell programming and a new way ... prizes of the 2009 Collegiate Inventors Competition, a program of ... Fund, the non-profit foundation of the global health care company ... Harris Wang, who invented a new way of cell ...
Cached Biology Technology:Is your microrobot up for the (NIST) challenge? 2Ohio Bioscience Industry Leads Midwest, Among Best in Nation as Investment Destination 2Winners Announced in 2009 Collegiate Inventors Competition(R) 2Winners Announced in 2009 Collegiate Inventors Competition(R) 3Winners Announced in 2009 Collegiate Inventors Competition(R) 4Winners Announced in 2009 Collegiate Inventors Competition(R) 5Winners Announced in 2009 Collegiate Inventors Competition(R) 6Winners Announced in 2009 Collegiate Inventors Competition(R) 7
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/10/2014)... began appearing on U.S. store shelves in early 2010, ... since. The small packets can be tossed into a ... liquid or powder. The convenience, though, has come with ... researchers at Nationwide Children,s Hospital found that from 2012 ... 17,230 children younger than 6 years of age swallowing, ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2
... suggests that a blood clot-dissolving medication that is administered ... may help to reduce the risk of amputation following ... issue of Archives of Surgery, one of the JAMA/Archives ... for the past 25 years, according to background information ...
... nanoparticle made in a laboratory at the University of ... device for treating glaucoma, an eye disease that can ... “The nanoparticle can safely get past the blood-brain barrier ... said Sudipta Seal, an engineering professor with appointments in ...
... of infections and other diseases of the brain is ... from reaching the brain. Grantees of the National Institute ... Institutes of Health, have now shown that a short ... strip of therapeutic material into the brain via intravenous ...
Cached Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2UCF nanoparticle offers promise for treating glaucoma 2Blood-brain barrier breached by new therapeutic strategy 2
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 19 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
... HydroFlex platform provides excellent performance, reliability ... 96-well format applications, including washing of ... and vacuum filtration-to-waste, such as for ... control features set new standards for ...
... Obtain Clean and Accurate Results Laser ... increase the sensitivity and accuracy of molecular ... cell types and multi-cellular structures isolated from ... approach to microdissection-developed in 1996 at the ...
...
Biology Products: